A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...
The randomised, double-blind, placebo-controlled Phase 2 TrIuMPH trial enrolled a total of 122 patients at two sites in the UK. Patients with confirmed severe IBS-C or IBS-D using Rome IV criteria ...